RESUMO
BACKGROUND: Lyme disease after a tick bite often presents as erythema migrans, yet less frequent variants of this disease, such as Borrelia lymphocytoma, multiple erythema migrans and neuroborreliosis, are also seen occasionally. CASE PRESENTATION: We report a case of a tick-bitten child who first presented with an indistinct macular erythema around the left eye and a more distinct macular erythema on and around the left ear. The next day, she developed a facial palsy. INTERPRETATION: The case was interpreted as facial multiple erythema migrans and Borrelia lymphocytoma on the ear, followed by neuroborreliosis. The diagnosis of lymphocytoma was made from clinical findings and PCR of skin biopsy. She recovered quickly after intravenous ceftriaxone and is now healthy.
Assuntos
Doença de Lyme , Pseudolinfoma , Dermatopatias Bacterianas , Criança , Feminino , Humanos , Otopatias/etiologia , Eritema Migrans Crônico/etiologia , Dermatoses Faciais/etiologia , Paralisia Facial/etiologia , Neuroborreliose de Lyme/etiologia , Pseudolinfoma/diagnóstico , Picadas de Carrapatos/complicações , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Dermatopatias Bacterianas/diagnósticoRESUMO
A previously healthy boy presented to the healthcare services on several occasions with pain in his knee, ankle and foot. Clinical examinations and additional diagnostic testing initially revealed no red flags, but after 5 months, the boy was diagnosed with a serious and unexpected condition.
Assuntos
Tornozelo , Dor , Articulação do Tornozelo , Humanos , Articulação do Joelho , Masculino , Dor/etiologia , Exame FísicoAssuntos
Diabetes Mellitus Tipo 1 , Coma Hiperglicêmico Hiperosmolar não Cetótico , Adolescente , Transtornos da Consciência/etiologia , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 1/terapia , Cetoacidose Diabética/complicações , Cetoacidose Diabética/diagnóstico , Cetoacidose Diabética/etiologia , Cetoacidose Diabética/terapia , Humanos , Coma Hiperglicêmico Hiperosmolar não Cetótico/complicações , Coma Hiperglicêmico Hiperosmolar não Cetótico/diagnóstico , Coma Hiperglicêmico Hiperosmolar não Cetótico/etiologia , Coma Hiperglicêmico Hiperosmolar não Cetótico/terapia , Masculino , Sede , Redução de PesoAssuntos
Corticosteroides/administração & dosagem , Antiasmáticos/administração & dosagem , Asma/prevenção & controle , Administração por Inalação , Corticosteroides/efeitos adversos , Adulto , Antiasmáticos/efeitos adversos , Criança , Progressão da Doença , Humanos , Guias de Prática Clínica como AssuntoAssuntos
Glucocorticoides , Infecções Respiratórias/tratamento farmacológico , Doença Aguda , Obstrução das Vias Respiratórias/tratamento farmacológico , Asma/tratamento farmacológico , Pré-Escolar , Glucocorticoides/efeitos adversos , Glucocorticoides/farmacologia , Glucocorticoides/uso terapêutico , Humanos , Laringite/tratamento farmacológico , Sons Respiratórios/efeitos dos fármacosRESUMO
OBJECT: It has recently been suggested that the degree of intracranial pressure (ICP) above the treatment goal can be estimated by the area under the curve (AUC) of ICP versus time in patients with severe traumatic brain injury (TBI). The objective of this study was to determine whether the calculated "ICP dose"-the ICP AUC-is related to mortality rate, outcome, and Marshall CT classification. METHODS: Of 135 patients (age range 1-82 years) with severe TBI treated during a 5-year period at the authors' institution, 113 patients underwent ICP monitoring (84%). Ninety-three patients with a monitoring time>24 hours were included for analysis of ICP AUC calculated using the trapezoidal method. Computed tomography scans were assessed according to the Marshall TBI classification. Patients with Glasgow Outcome Scale scores at 6 months and >3 years were separated into 2 groups based on outcome. RESULTS: Sixty patients (65%) had ICP values>20 mm Hg, and 12 (13%) developed severe intracranial hypertension and died secondary to herniation. A multiple regression analysis adjusting for Glasgow Coma Scale score, age, pupillary abnormalities and Injury Severity Scale score demonstrated that the ICP AUC was a significant predictor of poor outcome at 6 months (p=0.034) and of death (p=0.035). However, it did not predict long-term outcome (p=0.157). The ICP AUC was significantly higher in patients with Marshall head injury Categories 3 and 4 (24 patients) than in those with Category 2 (23 patients, p=0.025) and Category 5 (46 patients, p=0.021) TBIs using the worst CT scan obtained. CONCLUSIONS: The authors found a significant relationship between the dose of ICP, the worst Marshall CT score, and patient outcome, suggesting that the AUC method may be useful in refining and improving the treatment of ICP in patients with TBI.